Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4918 USD | +1.78% | +0.78% | -60.97% |
Mar. 11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
Mar. 04 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 27M |
---|---|---|---|---|---|
Net income 2024 * | -49M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-
| Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.72% |
1 day | +1.78% | ||
1 week | +0.78% | ||
Current month | -6.96% | ||
1 month | -14.56% | ||
3 months | -47.12% | ||
6 months | -84.91% | ||
Current year | -60.97% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.4918 | +1.78% | 704,400 |
24-04-22 | 0.4832 | -0.68% | 451,590 |
24-04-19 | 0.4865 | -0.39% | 531,966 |
24-04-18 | 0.4884 | +3.61% | 1,409,264 |
24-04-17 | 0.4714 | -3.40% | 610,796 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.97% | 27M | |
-0.49% | 105B | |
+3.31% | 97.5B | |
+2.39% | 22.19B | |
-16.16% | 21.33B | |
-7.42% | 18.68B | |
-41.41% | 16.6B | |
-22.87% | 14.52B | |
+6.32% | 14.09B | |
+21.46% | 10.99B |
- Stock Market
- Equities
- BIVI Stock